{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:00:22Z","timestamp":1793833222619,"version":"4.6.1"},"reference-count":32,"publisher":"American Society for Clinical Investigation","issue":"10","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,22]]},"abstract":"<jats:p>Multiple myeloma is a largely incurable and life-threatening malignancy of antibody-secreting plasma cells. An effective and widely available animal model that recapitulates human myeloma and related plasma cell disorders is lacking. We show that busulfan-conditioned human IL-6\u2013transgenic (hIL-6\u2013transgenic) NSG (NSG+hIL6) mice reliably support the engraftment of malignant and premalignant human plasma cells, including from patients diagnosed with monoclonal gammopathy of undetermined significance, pre- and postrelapse myeloma, plasma cell leukemia, and amyloid light chain amyloidosis. Consistent with human disease, NSG+hIL6 mice engrafted with patient-derived myeloma cells developed serum M spikes, and a majority developed anemia, hypercalcemia, and\/or bone lesions. Single-cell RNA sequencing showed nonmalignant and malignant cell engraftment, the latter expressing a wide array of mRNAs associated with myeloma cell survival and proliferation. Myeloma-engrafted mice given CAR T cells targeting plasma cells or bortezomib experienced reduced tumor burden. Our results establish NSG+hIL6 mice as an effective patient-derived xenograft model for study and preclinical drug development of multiple myeloma and related plasma cell disorders.<\/jats:p>","DOI":"10.1172\/jci.insight.177300","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:00:33Z","timestamp":1715083233000},"source":"Crossref","is-referenced-by-count":11,"title":["Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice"],"prefix":"10.1172","volume":"9","author":[{"given":"Zainul S.","family":"Hasanali","sequence":"first","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2791-5748","authenticated-orcid":true,"given":"Alfred L.","family":"Garfall","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Burzenski","sequence":"additional","affiliation":[{"name":"Jackson Laboratories, Bar Harbor, Maine, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard D.","family":"Shultz","sequence":"additional","affiliation":[{"name":"Jackson Laboratories, Bar Harbor, Maine, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Kadu","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil C.","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies,"},{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Dopkin","sequence":"additional","affiliation":[{"name":"Stem Cell and Xenograft Core Facility, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan T.","family":"Vogl","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-3843","authenticated-orcid":true,"given":"Adam D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Waxman","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra P.","family":"Susanibar-Adaniya","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-3735","authenticated-orcid":true,"given":"Martin","family":"Carroll","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."},{"name":"Stem Cell and Xenograft Core Facility, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Stadtmauer","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9345-1502","authenticated-orcid":true,"given":"David","family":"Allman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0141"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195008"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00414-6"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26569"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31594-X"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402551"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00135-5"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119546"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07387.x"},{"issue":"20","key":"B10","first-page":"6689","article-title":"Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID\/NOD in vivo model: biologic and clinical implications","volume":"63","author":"Mitsiades","year":"2003","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0785-1"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2437"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403513"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079939"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4202"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560031213"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.02.001"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26654"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/BF01714900"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3791\/52553"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00915.x"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00267-X"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature07064"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121632"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029355"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2012.37"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4137\/CGM.S16817"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25359"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126397"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V57.2.333.333"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197703)39:3<1077::AID-CNCR2820390311>3.0.CO;2-S"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-556340"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/177300\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:44:12Z","timestamp":1779137052000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/177300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,4,23]]},"published-print":{"date-parts":[[2024,5,22]]}},"alternative-id":["10.1172\/jci.insight.177300"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.177300","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.21.576547","asserted-by":"object"}]},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"article-number":"e177300"}}